64419-92-7 Usage
Description
Necrostatin-1, Inactive Control is a cell permeable thiohydantoin analog of Nec-1, which is designed to inhibit the process of necroptosis, a form of programmed necrosis in cells.
Used in Pharmaceutical Research:
Necrostatin-1, Inactive Control is used as a necroptosis inhibitor for pharmaceutical research purposes. It helps researchers understand the role of necroptosis in various diseases and conditions, and aids in the development of potential therapeutic agents targeting this process.
Used in Cell Biology Studies:
In cell biology studies, Necrostatin-1, Inactive Control is used as a tool to investigate the molecular mechanisms underlying necroptosis and its regulation. This helps in gaining insights into cell death pathways and their implications in health and disease.
Used in Drug Screening:
Necrostatin-1, Inactive Control is utilized in drug screening assays to identify potential compounds that can modulate necroptosis. This is crucial for the development of new therapeutic strategies targeting necroptosis-related diseases.
Used in Disease Model Development:
In the development of disease models, Necrostatin-1, Inactive Control is used to study the role of necroptosis in the pathogenesis of various conditions, such as neurodegenerative disorders, ischemic injuries, and inflammatory diseases. This helps in understanding the contribution of necroptosis to disease progression and identifying potential therapeutic targets.
Check Digit Verification of cas no
The CAS Registry Mumber 64419-92-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,4,4,1 and 9 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 64419-92:
(7*6)+(6*4)+(5*4)+(4*1)+(3*9)+(2*9)+(1*2)=137
137 % 10 = 7
So 64419-92-7 is a valid CAS Registry Number.
64419-92-7Relevant articles and documents
Inhibitors of cellular necrosis
-
Page/Page column 35, (2008/06/13)
The present invention relates to compounds and pharmaceutical preparations and their use in therapy for preventing or treating trauma, ischemia, stroke and degenerative diseases associated with cell death. Methods and compositions of the invention are particularly useful for treating neurological disorders associated with cellular necrosis.
